Market closedNon-fractional
Revvity/RVTY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Revvity
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Ticker
RVTY
Sector
Healthcare
Trading on
NYSE
Industry
Life Sciences Tools and Services
Headquarters
Waltham, United States
Employees
11,500
Website
www.revvity.com
Revvity Metrics
BasicAdvanced
$14B
Market cap
93.86
P/E ratio
$1.20
EPS
1.09
Beta
$0.28
Dividend rate
0.25%
Dividend yield
Price and volume
Market cap
$14B
Beta
1.09
Dividend rate
$0.28
Financial strength
Current ratio
2.226
Quick ratio
1.662
Long term debt to equity
41.957
Total debt to equity
51.024
Dividend payout ratio (TTM)
23.23%
Interest coverage (TTM)
3.41%
Management effectiveness
Return on assets (TTM)
1.53%
Return on equity (TTM)
2.31%
Valuation
Price to earnings (TTM)
93.862
Price to revenue (TTM)
5.132
Price to book
1.78
Price to tangible book (TTM)
-8.87
Price to free cash flow (TTM)
144.042
Dividend yield (TTM)
0.25%
Growth
Revenue change (TTM)
-9.85%
Earnings per share change (TTM)
-84.23%
3-year revenue growth (CAGR)
-15.00%
3-year earnings per share growth (CAGR)
-49.91%
What the Analysts think about Revvity
Analyst Ratings
Majority rating from 19 analysts.
Revvity Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$650M
-6.61%
Net income
$26M
-66.88%
Profit margin
4.00%
-64.54%
Revvity Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.21
$1.18
$1.25
$0.98
-
Expected
$1.19
$1.19
$1.16
$0.93
$1.13
Surprise
2.09%
-1.07%
7.42%
5.05%
-
Revvity News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
Aug
9
Revvity
Dividend·Payment
$0.07
Per share
Oct
18
Revvity
Dividend·Ex-dividend
Nov
8
Revvity
Dividend·Payment
$0.07
Per share
FAQs
What’s the current market cap for Revvity stock?
Revvity (RVTY) has a market cap of $14B as of July 26, 2024.
What is the P/E ratio for Revvity stock?
The price to earnings (P/E) ratio for Revvity (RVTY) stock is 93.86 as of July 26, 2024.
Does Revvity stock pay dividends?
Yes, the Revvity (RVTY) stock pays dividends to shareholders. As of July 26, 2024, the dividend rate is $0.28 and the yield is 0.25%. Revvity has a payout ratio of 23.23% on a trailing twelve-month basis.
When is the next Revvity dividend payment date?
The next Revvity (RVTY) dividend payment is scheduled for August 09, 2024.
What is the beta indicator for Revvity?
Revvity (RVTY) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Revvity stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.